Enzon Pharmaceuticals (Piscataway, New Jersey)
Research & Development Facility
20 Kingsbridge Road
Piscataway
New Jersey
08854-3998
United States
Tel: 732-980-4500
Fax: 732-980-5911
Website: http://www.enzon.com/
30 articles about Enzon Pharmaceuticals (Piscataway, New Jersey)
-
Enzon Pharmaceuticals, Inc. Concludes Review of Possible Asset Sales, Sale of the Company; Announces $1.60 Special Dividend and Periodic Royalty Dividends
4/24/2013
-
Enzon Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2012 Results
3/19/2013
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Announces Special Dividend
11/30/2012
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Announces Two Oral Presentations at the Symposium of Drug Delivery Systems in Nanjing, China
11/8/2012
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Reports Second Quarter 2012 Results
8/1/2012
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Announces Data From Phase I Study of PEG-SN38 in Pediatric Neuroblastoma and Other Solid Tumors Presented at 2012 Advances in Neuroblastoma Research Conference
6/19/2012
-
Enzon Pharmaceuticals, Inc. and Hisun Announce Strategic Alliance for Enzon's Customized PEGylation Linker Technology and Licensing Agreement for PEG-SN38 in China
5/7/2012
-
Enzon Pharmaceuticals, Inc. Reports First Quarter 2012 Results
5/2/2012
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer Meeting
11/14/2011
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Reports 3rd Quarter 2011 Results
11/4/2011
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Announces Management Change, Forms Special Committee of the Board
10/18/2011
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Awarded $1.2 Million in Grants under QTDP Program
11/3/2010
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Sets Date of 2010 Annual Meeting
5/7/2010
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Will Present New Data on LNA and PEGylation Programs
4/14/2010
-
Enzon Pharmaceuticals (Piscataway, New Jersey) to Release Third Quarter 2009 Earnings on Tuesday, November 3, 2009; Conference Call and Webcast to Follow
10/28/2009
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Reports 2nd Quarter 2009 Results
8/4/2009
-
Santaris Pharma A/S: LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
6/4/2009
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Reports 2008 Results
2/19/2009
-
Enzon Pharmaceuticals (Piscataway, New Jersey) to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow
2/13/2009
-
Enzon Pharmaceuticals (Piscataway, New Jersey) Co-founder Returns with New Biotech, Prolong Pharmaceuticals
8/12/2008